Ain Holdings Inc. · TSE:9627
Ain — Q1 FY4/21 Earnings Presentation
29 slides from Ain's earnings presentation, September 2020
Slide 1: FY4/21 1Q IR Presentation
FY4/21 1Q IR PRESENTATION September 2020
Slide 2: Results Overview
Results Overview © 2020 AIN HOLDINGS INC. All Rights Reserved. 1
Slide 3: Consolidated P/L
Consolidated P/L Net sales decreased 1.4% YoY and 0.6% against the plan due to the impact of the COVID-19 outbreak, despite the contribution of 6 stores opened(including M&A) in this fiscal year and store opened in previous year. Ordinary income declined 60.7% YoY due to net sales lower than forecas
Slide 4: Dispensing Pharmacy Business (Consolidated)
Dispensing Pharmacy Business (Consolidated) Net sales decreased 3.0% YoY and 0.7% against the plan due to the impact of the COVID-19 outbreak. Segment income declined 28.0% YoY due to decrease of net sales and up 2.6% against the plan due to reduction of administrative expense. FY4/20 1Q FY4/21 1Q F
Slide 5: Cosmetic and Drug Store Business (Consolidated)
Cosmetic and Drug Store Business (Consolidated) Net sales declined 34.5% YoY and up 2.3% against the plan due to temporarily closed or shorted opening hours at many stores, despite the group has opened 3 stores in this fiscal year. Segment loss was ¥292 million due to net sales declined. FY4/20 1Q F
Slide 6: Consolidated B/S
Consolidated B/S Net cash became ¥36,719 million and shareholders’ equity ratio became 58.4%. We are maintaining a sound financial structure even during the COVID-19 outbreak. (¥ million) (¥ million) End-FY4/20 End-FY4/21 1Q Assets Liabilities Assets Liabilities Current assets 74,700 Current assets
Slide 7: Assets
Assets The balance of total assets decreased ¥5,226 million from the end of the previous fiscal year due to decrease of cash on hand and in banks and accounts receivable. End-FY4/20 1Q End-FY4/20 End-FY4/21 1Q Change (¥ million) Cash on hand and in banks 40,753 46,321 42,128 (4,193) Notes and accoun
Slide 8: Liabilities and Net Assets
Liabilities and Net Assets The balance of liabilities decreased ¥4,129 million from the end of the previous fiscal year due to decrease of accounts payable. (¥ million) End-FY4/20 1Q End-FY4/20 End-FY4/21 1Q Change Accounts payable 46,194 47,187 45,334 (1,853) Short-term debt 5,045 3,642 3,171 (471)
Slide 9: FY4/21 Plan (Consolidated)
FY4/21 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2021 increase 6.3% and ordinary income decrease 10.8% YoY by open new stores (50 dispensing pharmacies and 12 cosmetic and drug stores). FY4/19 FY4/20 FY4/21 YoY YoY （¥ million） results results plan change
Slide 10: Review / Revision of 2020 / Growth strategy
Review Revision of 2020 Growth strategy © 2020 AIN HOLDINGS INC. All Rights Reserved. 9
Slide 11: Review
Review © 2020 AIN HOLDINGS INC. All Rights Reserved. 10
Slide 12: Review (YoY)
Review（YoY） Net sales declined 1 billion and ordinary income decreased 2.6 billion due to the impact of the COVID-19 outbreak, despite the contribution of stores opened(including M&A) in previous year, but decline in the number of prescriptions and temporarily closed or shortened the opening hours o
Slide 13: Review (Vs plan)
Review（Vs plan） Net sales fell 0.5 billion against the plan due to the impact of the COVID-19 outbreak, while ordinary income increased 0.5 billion against the plan due to cost reduction. Net sales ¥(0.5) billion Ordinary income +¥0.5 billion ¥71.9 billion ¥71.4 billion ¥1.6 billion Dispensing Dispe
Slide 14: Revision of 2020
Revision of 2020 © 2020 AIN HOLDINGS INC. All Rights Reserved. 13
Slide 15: Responsive to revision of 2020 premiums
Responsive to revision of 2020 Object: 1,060 existing stores Basic dispensing fee Community support system premiums 1（42pts） 2（26pts） 3-Ⅱ（16pts） SP.（9pts） No Premiums Community support system premiums(38pts) 1,000 1,000 434 427 448 449 329 355 363 371 Stores Stores 9 10 7 7 500 500 597 602 582 5
Slide 16: Growth strategy
Growth strategy © 2020 AIN HOLDINGS INC. All Rights Reserved. 15
Slide 17: Growth Strategy
Growth Strategy Considering the institutional changes and deregulation in future, the Group continues to open high potential stores and reinforcing the Group’s business base. ■ Top-line Expanding of business by active new store openings in prime location and by secure M&As AIN Pharmacy DOKKYOIDAI ■
Slide 18: Opening (Top-line)
Top-line The group opened 6 stores including M&A, and closed 12 stores during the FY4/21 1Q. ■ Total number of stores 1,145 (Dispensing pharmacy:1,081、Cosmetic and drug store:64) FY4/21 1Q FY4/21 ■ Plan Hokkaido Plan Results Plan 119 Dispensing 4 3 50 Pharmacy Opening Organic 1 1 28 Koshinetsu M&A 3
Slide 19: M&A
M&A The Group have only acquired 2 dispensing pharmacies during the period, as we continue to focus on investing in better deals from previous fiscal year, but we are actively collecting information. ■ M&A criteria M&A criteria Our targets Annual net sales more than Annual net sales ¥200 million Sto
Slide 20: Reinforcing the Group's business base
Reinforcing the Group’s business base We aim to reinforcing the Group’s business base by actively investing in ICT, logistics, and Group brand building that will support our future growth. Investment projects Subject ■ ICT・Logistics Securing specialized Proactively hiring people with expertise in IT
Slide 21: Recruiting
Recruiting In April 2020, new 560 pharmacists has joined our group. For Strengthening the function of pharmacies such as home-based healthcare and the primary care services, and for large scale new opening, securing a pharmacist through recruiting and training human resources is a major strength for
Slide 22: The function of pharmacies
The function of pharmacies In terms of functions such as promotion of GE use, home-based health care and primary care services, which have been demanded by the country and patients, we have accumulated high achievements compared with pharmacies nationwide. Comparison of results (As of March 2020)
Slide 23: Revised Pharmaceuticals and Medical Devices Act
Revised Pharmaceuticals and Medical Devices Act Pharmaceuticals and Medical Devices Act has been revised on September 1, 2020. The group continues Strengthening the function of pharmacies. Date of Content implementation Required to follow- Pharmacists will be required as necessary to ascertain drug
Slide 24: Online drug guidance
Online drug guidance Online drug guidance became available nationwide on September 1. Since special measures (0410 government announcement) for preventing the spread of COVID-19 are still effective, it have to explain carefully to those who wish to use this service. ■ History of online drug guidance
Slide 25: Expansion of ainz & tulpe①
Expansion of ainz & tulpe① Sapporo ※Planning ainz & tulpe new store opening in FY4/21 12Stores ※Other 3 stores are under planning Tohoku ※Planning Tokyu plaza totsuka （Scheduled to open in Sep 18, 2020） Daimaru Kyoto (5/6/2020) Daimaru Umeda Hibiya chanter （10/7/2020) (5/6/2020) Tokyo ※Planning Kyus
Slide 26: Expansion of ainz & tulpe②
Expansion of ainz & tulpe② The group launched the official ainz & tulpe app which can also manage points in October 2019 and an EC website in May 2020. In this August, official app and EC website were linked to improved customer satisfaction by reducing sales opportunity loss and optimized store inv
Slide 27: FY4/21 Plan (Consolidated)
FY4/21 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2021 increase 6.3% and ordinary income decrease 10.8% YoY by open new stores (50 dispensing pharmacies and 12 cosmetic and drug stores). FY4/19 FY4/20 FY4/21 YoY YoY （¥ million） results results plan change
Slide 28: AIN HOLDINGS INC. Corporate Planning Division
Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document ha
Slide 29: AIN GROUP
AIN GROUP